FBR Capital Upgrades Core Laboratories (CLB) to Outperform on 'Very Strong' Q4

Go back to FBR Capital Upgrades Core Laboratories (CLB) to Outperform on 'Very Strong' Q4

Core Laboratories N.v. (CLB) Tops Q4 EPS by 4c; Guides Q1, FY13

January 30, 2013 5:39 PM EST

Core Laboratories N.v. (NYSE: CLB) reported Q4 EPS of $1.17, $0.04 better than the analyst estimate of $1.13. Revenue for the quarter came in at $254.46 million versus the consensus estimate of $246.49 million.

Core Laboratories N.v. sees Q1 2013 EPS of $1.12-1.18, versus the consensus of... More